Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9Y5X4: Variant p.Leu353Val

Photoreceptor-specific nuclear receptor
Gene: NR2E3
Feedback?
Variant information Variant position: help 353 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Leucine (L) to Valine (V) at position 353 (L353V, p.Leu353Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In ESCS; impairs protein folding and stability. Any additional useful information about the variant.


Sequence information Variant position: help 353 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 410 The length of the canonical sequence.
Location on the sequence: help TRGLKDPEHVEALQDQSQVM L SQHSKAHHPSQPVRFGKLLL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         TRGLKDPEHVEALQDQSQVMLSQHSKAHHPSQPVRFGKLLL

Mouse                         TRGLKDPEHVEALQDQSQVMLSQHSKAHHPSQPVRFGKLLL

Bovine                        TRGLKDPEHVEALQDQSQVMLSQHSKAHHPSQLVRFGKLLL
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 410 Photoreceptor-specific nuclear receptor
Domain 169 – 410 NR LBD
Cross 337 – 337 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
Mutagenesis 372 – 372 L -> R. Reduces transcription repressor activity.
Helix 339 – 360



Literature citations
The crystal structure of the orphan nuclear receptor NR2E3/PNR ligand binding domain reveals a dimeric auto-repressed conformation.
Tan M.H.; Zhou X.E.; Soon F.F.; Li X.; Li J.; Yong E.L.; Melcher K.; Xu H.E.;
PLoS ONE 8:E74359-E74359(2013)
Cited for: X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 217-410; SUBUNIT; MUTAGENESIS OF LEU-372 AND LEU-375; FUNCTION; CHARACTERIZATION OF VARIANT ASSOCIATED WITH ESCS GLY-334; CHARACTERIZATION OF VARIANTS ESCS PRO-263; GLY-309; GLN-311; PRO-336; VAL-353 AND LYS-407; Mutation analysis of NR2E3 and NRL genes in enhanced S cone syndrome.
Wright A.F.; Reddick A.C.; Schwartz S.B.; Ferguson J.S.; Aleman T.S.; Kellner U.; Jurklies B.; Schuster A.; Zrenner E.; Wissinger B.; Lennon A.; Shu X.; Cideciyan A.V.; Stone E.M.; Jacobson S.G.; Swaroop A.;
Hum. Mutat. 24:439-439(2004)
Cited for: VARIANTS ESCS 67-CYS--GLY-69 DEL; VAL-88; HIS-97; TRP-104; SER-234; GLU-256; PRO-263; GLY-309; GLN-311; PRO-336; VAL-353 AND LYS-407;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.